Cage Bio
PrivateLast Round
Series A
Feb 16, 2021
Total Funding Raised
$12.71M
Company Overview
Cage Bio is a biotechnology company that develops a eutectic ionic liquid aimed at reducing the reliance on systemic drugs for treating dermal diseases, leveraging ionic liquid technology to provide broad-spectrum antimicrobial and anti-inflammatory benefits while improving solubility and permeability for effective dermatological treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cage Bio Comps
Public and private peers based on sector, stage, and business model.
Cage Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 16, 2021 | ||||
| Seed | Jul 3, 2019 |
Cage Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Propel(x) | Series A |
| AG Collective Capital | Series A |
| MBC BioLabs | Series A, Seed |
| Cowtown Angels | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2025
Initiated double-blind trial for vitiligo therapy CGB-600.
Cage Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cage Bio's valuation, stock price, and market status.
